China develops nanomaterial to combat COVID-19: Report
A team of Chinese scientists has reportedly developed a novel way to combat the new coronavirus that causes the Covid-19 disease which has killed over 32,000 people globally. According to…
Alcohol based Sanitizer leads to Burn Injury
New Delhi: Sanitizer, which is essential to prevent COVID infection, caused serious burn to man who is being, treated @Sir Ganga Ram Hospital. The doctor has warned that sanitizers must…
Apollo Hospitals Group ropes in Hotels to create COVID Corridor
India : Apollo hospitals group has created a COVID Corridor for moneyed class starting with isolation room in hotel, testing, supervision through telemedicine till high end treatment. The project named…
Over 6,500 Sch M units to improve product quality through Guidelines on post-approval changes in drugs: Regulatory experts
According to regulatory experts, The much awaited guidelines on post-approval changes to pharmaceutical products, which is under the draft stage as of now, can help over 6,500 Schedule M units…
Malaria drug is biggest hope against coronavirus: Novartis CEO
Swiss newspaper SonntagsZeitung reported that Novartis Chief Executive Vas Narasimhan said his Sandoz generics unit’s malaria, lupus and arthritis drug hydroxychloroquine is the company’s biggest hope against the coronavirus. Novartis…
MEDICAL DEVICES TO BE USED AS DRUGS: UNION HEALTH MINISTRY
A regulation has been passed by Union Health Ministry under which all medical devices used either on human beings or animals would be treated as drugs from April 1 this…
COVID 19 TREATMENT: C2 PHARMA opens research access to safety stock of Digoxin API
A Luxembourg-based phytochemical and chemical pharmaceutical manufacturing and distribution group C2 PHARMA s.a.r.l. (C2P), is announcing that they will open the door to access safety stocks of the active pharmaceutical…
NPPA asks states, UTs to ensure unobstructed movement of stock, manpower
The National Pharmaceutical Pricing Authority (NPPA) has asked all states as well as union territories to ensure movement without interruption of stock and manpower of pharma companies due to coronavirus-induced…
Hoarding of Hydroxychloroquine leads to shortage as the same becomes a Schedule H1 drug
MUMBAI: The Ministry of Health on Thursday, through a special amendment has categorised hydroxychloroquine (HCQS) drug as a schedule H1 drug- which states that it cannot be sold as over…
Unrealistic Optimism may be behind Breaking COVID 19 Lockdown & Curfew: Survey
New Delhi: Ahead of curfew and lockdown to cut-down on COVID-19 pandemic’s spread, people have been found violating the norms of this effective deterrent. In a quick survey, Healthy Nudge…
